Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis

Identifieur interne : 008A19 ( Main/Exploration ); précédent : 008A18; suivant : 008A20

Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis

Auteurs : P. Marquis [États-Unis] ; C. Roux [France] ; C. De La Loge [France] ; M. Diaz-Curiel [Espagne] ; C. Cormier [France] ; G. Isaia [Italie] ; J. Badurski [Pologne] ; J. Wark [Australie] ; P. J. Meunier [France]

Source :

RBID : Pascal:08-0187121

Descripteurs français

English descriptors

Abstract

Strontium ranelate reduces the risk of fracture in post-menopausal osteoporotic women with prevalent fractures for whom quality of life is severely impaired. The SOTI study, which used the SF-36® questionnaire and disease-specific QUALIOST® module, demonstrated that treatment with strontium ranelate improved osteoporotic women's quality of life compared with placebo. Introduction The Spinal Osteoporosis Therapeutic Intervention (SOTI) study demonstrated the effect of orally administered strontium ranelate versus placebo on the incidence of new vertebral fractures and compared impact on quality of life (QoL). Methods QoL was assessed 6 monthly over 3 years using the QUALIOST® and SF-36® questionnaires in post-menopausal osteoporotic women with prevalent fracture taking strontium ranelate or placebo 2 g/day. A total of 1,240 women were included (strontium ranelate: n=618 and placebo: n= 622). Results The QUALIOST® total score decreased in the strontium ranelate group, indicating preserved QoL compared with a deterioration in the placebo group (P=0.016). Strontium ranelate patients had reduced QUALIOST® emotional and physical dimension scores (P=0.019 and 0.032, respectively, versus placebo), indicating beneficial effects on emotional and physical functioning. There was a trend towards better SF-36® scores in the strontium ranelate group, although there were no significant between-group differences. More strontium ranelate patients (+ 31%) were free from back pain over 3 years versus placebo (P=0.005), with a significant effect from the first year of treatment (P= 0.023). Conclusion Strontium ranelate has beneficial effects on QoL in women with post-menopausal osteoporosis compared with placebo.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis</title>
<author>
<name sortKey="Marquis, P" sort="Marquis, P" uniqKey="Marquis P" first="P." last="Marquis">P. Marquis</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Mapi Values, 15 Court Square Suite 620</s1>
<s2>Boston, MA 02108</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Boston, MA 02108</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Roux, C" sort="Roux, C" uniqKey="Roux C" first="C." last="Roux">C. Roux</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Service de Rhumatologie B, Hôpital Cochin</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="De La Loge, C" sort="De La Loge, C" uniqKey="De La Loge C" first="C." last="De La Loge">C. De La Loge</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Mapi Values</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Diaz Curiel, M" sort="Diaz Curiel, M" uniqKey="Diaz Curiel M" first="M." last="Diaz-Curiel">M. Diaz-Curiel</name>
<affiliation wicri:level="3">
<inist:fA14 i1="04">
<s1>Jimenez Diaz Foundation</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cormier, C" sort="Cormier, C" uniqKey="Cormier C" first="C." last="Cormier">C. Cormier</name>
<affiliation wicri:level="3">
<inist:fA14 i1="05">
<s1>Service de Rhumatologie A, Hôpital Cochin</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Isaia, G" sort="Isaia, G" uniqKey="Isaia G" first="G." last="Isaia">G. Isaia</name>
<affiliation wicri:level="3">
<inist:fA14 i1="06">
<s1>Dipartimento di Medicina Interna Université di Torino</s1>
<s2>Torino</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName>
<settlement type="city">Turin</settlement>
<region type="région" nuts="2">Piémont</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Badurski, J" sort="Badurski, J" uniqKey="Badurski J" first="J." last="Badurski">J. Badurski</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Polish Center of Osteoporosis</s1>
<s2>Bialystok</s2>
<s3>POL</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Pologne</country>
<wicri:noRegion>Polish Center of Osteoporosis</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wark, J" sort="Wark, J" uniqKey="Wark J" first="J." last="Wark">J. Wark</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Royal Melbourne Hospital</s1>
<s2>Parkville Vic</s2>
<s3>AUS</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Royal Melbourne Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Meunier, P J" sort="Meunier, P J" uniqKey="Meunier P" first="P. J." last="Meunier">P. J. Meunier</name>
<affiliation wicri:level="3">
<inist:fA14 i1="09">
<s1>Faculté Laennec</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">08-0187121</idno>
<date when="2008">2008</date>
<idno type="stanalyst">PASCAL 08-0187121 INIST</idno>
<idno type="RBID">Pascal:08-0187121</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003659</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002987</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002E85</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">002E85</idno>
<idno type="wicri:doubleKey">0937-941X:2008:Marquis P:strontium:ranelate:prevents</idno>
<idno type="wicri:Area/Main/Merge">009299</idno>
<idno type="wicri:Area/Main/Curation">008A19</idno>
<idno type="wicri:Area/Main/Exploration">008A19</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis</title>
<author>
<name sortKey="Marquis, P" sort="Marquis, P" uniqKey="Marquis P" first="P." last="Marquis">P. Marquis</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Mapi Values, 15 Court Square Suite 620</s1>
<s2>Boston, MA 02108</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Boston, MA 02108</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Roux, C" sort="Roux, C" uniqKey="Roux C" first="C." last="Roux">C. Roux</name>
<affiliation wicri:level="3">
<inist:fA14 i1="02">
<s1>Service de Rhumatologie B, Hôpital Cochin</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="De La Loge, C" sort="De La Loge, C" uniqKey="De La Loge C" first="C." last="De La Loge">C. De La Loge</name>
<affiliation wicri:level="3">
<inist:fA14 i1="03">
<s1>Mapi Values</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Diaz Curiel, M" sort="Diaz Curiel, M" uniqKey="Diaz Curiel M" first="M." last="Diaz-Curiel">M. Diaz-Curiel</name>
<affiliation wicri:level="3">
<inist:fA14 i1="04">
<s1>Jimenez Diaz Foundation</s1>
<s2>Madrid</s2>
<s3>ESP</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Espagne</country>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cormier, C" sort="Cormier, C" uniqKey="Cormier C" first="C." last="Cormier">C. Cormier</name>
<affiliation wicri:level="3">
<inist:fA14 i1="05">
<s1>Service de Rhumatologie A, Hôpital Cochin</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Isaia, G" sort="Isaia, G" uniqKey="Isaia G" first="G." last="Isaia">G. Isaia</name>
<affiliation wicri:level="3">
<inist:fA14 i1="06">
<s1>Dipartimento di Medicina Interna Université di Torino</s1>
<s2>Torino</s2>
<s3>ITA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Italie</country>
<placeName>
<settlement type="city">Turin</settlement>
<region type="région" nuts="2">Piémont</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Badurski, J" sort="Badurski, J" uniqKey="Badurski J" first="J." last="Badurski">J. Badurski</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Polish Center of Osteoporosis</s1>
<s2>Bialystok</s2>
<s3>POL</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Pologne</country>
<wicri:noRegion>Polish Center of Osteoporosis</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Wark, J" sort="Wark, J" uniqKey="Wark J" first="J." last="Wark">J. Wark</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Royal Melbourne Hospital</s1>
<s2>Parkville Vic</s2>
<s3>AUS</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Royal Melbourne Hospital</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Meunier, P J" sort="Meunier, P J" uniqKey="Meunier P" first="P. J." last="Meunier">P. J. Meunier</name>
<affiliation wicri:level="3">
<inist:fA14 i1="09">
<s1>Faculté Laennec</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Osteoporosis international</title>
<title level="j" type="abbreviated">Osteoporos. int.</title>
<idno type="ISSN">0937-941X</idno>
<imprint>
<date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Osteoporosis international</title>
<title level="j" type="abbreviated">Osteoporos. int.</title>
<idno type="ISSN">0937-941X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Fracture</term>
<term>Osteoporosis</term>
<term>Prevention</term>
<term>Quality of life</term>
<term>Rheumatology</term>
<term>Strontium ranelate</term>
<term>Vertebra</term>
<term>Woman</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Ranélate de strontium</term>
<term>Prévention</term>
<term>Qualité de vie</term>
<term>Femme</term>
<term>Vertèbre</term>
<term>Ostéoporose</term>
<term>Fracture</term>
<term>Rhumatologie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Femme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Strontium ranelate reduces the risk of fracture in post-menopausal osteoporotic women with prevalent fractures for whom quality of life is severely impaired. The SOTI study, which used the SF-36® questionnaire and disease-specific QUALIOST® module, demonstrated that treatment with strontium ranelate improved osteoporotic women's quality of life compared with placebo. Introduction The Spinal Osteoporosis Therapeutic Intervention (SOTI) study demonstrated the effect of orally administered strontium ranelate versus placebo on the incidence of new vertebral fractures and compared impact on quality of life (QoL). Methods QoL was assessed 6 monthly over 3 years using the QUALIOST® and SF-36® questionnaires in post-menopausal osteoporotic women with prevalent fracture taking strontium ranelate or placebo 2 g/day. A total of 1,240 women were included (strontium ranelate: n=618 and placebo: n= 622). Results The QUALIOST® total score decreased in the strontium ranelate group, indicating preserved QoL compared with a deterioration in the placebo group (P=0.016). Strontium ranelate patients had reduced QUALIOST® emotional and physical dimension scores (P=0.019 and 0.032, respectively, versus placebo), indicating beneficial effects on emotional and physical functioning. There was a trend towards better SF-36® scores in the strontium ranelate group, although there were no significant between-group differences. More strontium ranelate patients (+ 31%) were free from back pain over 3 years versus placebo (P=0.005), with a significant effect from the first year of treatment (P= 0.023). Conclusion Strontium ranelate has beneficial effects on QoL in women with post-menopausal osteoporosis compared with placebo.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>Espagne</li>
<li>France</li>
<li>Italie</li>
<li>Pologne</li>
<li>États-Unis</li>
</country>
<region>
<li>Auvergne-Rhône-Alpes</li>
<li>Communauté de Madrid</li>
<li>Piémont</li>
<li>Rhône-Alpes</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Lyon</li>
<li>Madrid</li>
<li>Paris</li>
<li>Turin</li>
</settlement>
</list>
<tree>
<country name="États-Unis">
<noRegion>
<name sortKey="Marquis, P" sort="Marquis, P" uniqKey="Marquis P" first="P." last="Marquis">P. Marquis</name>
</noRegion>
</country>
<country name="France">
<region name="Île-de-France">
<name sortKey="Roux, C" sort="Roux, C" uniqKey="Roux C" first="C." last="Roux">C. Roux</name>
</region>
<name sortKey="Cormier, C" sort="Cormier, C" uniqKey="Cormier C" first="C." last="Cormier">C. Cormier</name>
<name sortKey="De La Loge, C" sort="De La Loge, C" uniqKey="De La Loge C" first="C." last="De La Loge">C. De La Loge</name>
<name sortKey="Meunier, P J" sort="Meunier, P J" uniqKey="Meunier P" first="P. J." last="Meunier">P. J. Meunier</name>
</country>
<country name="Espagne">
<region name="Communauté de Madrid">
<name sortKey="Diaz Curiel, M" sort="Diaz Curiel, M" uniqKey="Diaz Curiel M" first="M." last="Diaz-Curiel">M. Diaz-Curiel</name>
</region>
</country>
<country name="Italie">
<region name="Piémont">
<name sortKey="Isaia, G" sort="Isaia, G" uniqKey="Isaia G" first="G." last="Isaia">G. Isaia</name>
</region>
</country>
<country name="Pologne">
<noRegion>
<name sortKey="Badurski, J" sort="Badurski, J" uniqKey="Badurski J" first="J." last="Badurski">J. Badurski</name>
</noRegion>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Wark, J" sort="Wark, J" uniqKey="Wark J" first="J." last="Wark">J. Wark</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008A19 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008A19 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:08-0187121
   |texte=   Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024